Page 2 - Agent Capital News Today

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Jana Care, Inc., the pioneering developer of at-home self-administered testing technologies for chronic kidney and heart disease management,...

Jana Care, Inc., the pioneering developer of at-home self-administered testing technologies for chronic kidney and heart disease management, today...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

– Star’s innovation engine has driven rapid advancement of internally discovered first‑in‑class antibody therapeutics into the clinic, attracting leading life sciences investors– Financing supports Vega Therapeutics, a clinical stage company focused on underserved blood disorders, as well as the advancement of addit...

Startup Star Therapeutics will use the Series B funding to support clinical development of a drug candidate for von Willebrand disease, a bleeding disorder. The capital will also support the formation of new biotech subsidiaries developing antibodies with therapeutic applications in hematology and immunology.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Orbital’s $270 million Series A and MiNA’s Therapeutics’ collaboration with BioMarin Pharmaceutical bring RNA medicines closer to treating human disease.

The Cambridge startup’s successful first fund-raising round defies the biotech industry’s slump.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!